Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.
Ontology highlight
ABSTRACT: Immunotherapies are rapidly being integrated into standard of care (SOC) therapy in conjunction with surgery, chemotherapy, and radiotherapy for many cancers and a large number of clinical studies continue to explore immunotherapy alone and as part of combination therapies in patients with cancer. It is evident that clinical effectiveness of immunotherapy is limited to a subset of patients and improving immunotherapy related outcomes remains a major scientific and clinical effort. Understanding the immune cell subset phenotype and activation/functional status (cellular immunome) prior to and post therapy is therefore critical to develop biomarkers that (1) will predict if a patient will respond to immunotherapy and (2) are a result of immunotherapy. In this study, we investigated local (tu
SUBMITTER: Holl EK
PROVIDER: S-EPMC6685102 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA